Trial Profile
The status of essential trace metals and the efficacy of zinc supplementation in depressive disorders
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 14 Jun 2018
Price :
$35
*
At a glance
- Drugs Polaprezinc (Primary)
- Indications Depressive disorders
- Focus Pharmacodynamics; Therapeutic Use
- 14 Jun 2018 New trial record